153 related articles for article (PubMed ID: 10600300)
1. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma.
Fanning J; Bennett TZ; Hilgers RD
Obstet Gynecol; 1992 Dec; 80(6):954-60. PubMed ID: 1333066
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of cyclophosphamide, doxorubicin, and cisplatin in advanced breast cancer.
Kochupillai V; Gupta P; Misra A
Am J Clin Oncol; 1992 Oct; 15(5):388-91. PubMed ID: 1524038
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.
Kane R; Harvey H; Andrews T; Bernath A; Curry S; Dixon R; Gottlieb R; Kukrika M; Lipton A; Mortel R; Ricci J; White D
Cancer Treat Rep; 1979 Feb; 63(2):307-9. PubMed ID: 109201
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
[TBL] [Abstract][Full Text] [Related]
7. [Clinical trial of China-made carboplatin in advanced ovarian cancer--an analysis of 53 cases].
Liu LY
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):461-3. PubMed ID: 1304482
[TBL] [Abstract][Full Text] [Related]
8. The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).
Vogl SE; Berenzweig M; Kaplan BH; Moukhtar M; Bulkin W
Cancer Treat Rep; 1979 Feb; 63(2):311-7. PubMed ID: 109202
[TBL] [Abstract][Full Text] [Related]
9. [Phase III study of DWA2114R for ovarian cancer].
Kato T; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Yamabe T; Yajima A; Fujimoto S; Hashimoto M; Nishiya I
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1285-93. PubMed ID: 1503482
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of cisplatin alone and in combination within the scope of primary therapy of ovarian cancer. Results of a prospective multicenter study].
Richter P; Krafft W; Müller U; Brückmann D; Homann S; König EM; Lotze P; Morack G; Neubert S; Nöschel H
Zentralbl Gynakol; 1990; 112(7):421-9. PubMed ID: 1695049
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.
Alberts DS; Hilgers RD; Moon TE; Martimbeau PW; Rivkin S
Cancer Treat Rep; 1979 Feb; 63(2):301-5. PubMed ID: 109200
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of cisplatin administration with low-volume hydration and glutathione protection in the treatment of ovarian carcinoma.
Bohm S; Battista Spatti G; Di Re F; Oriana S; Pilotti S; Tedeschi M; Tognella S; Zunino F
Anticancer Res; 1991; 11(4):1613-6. PubMed ID: 1746919
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.
Conte PF; Bruzzone M; Carnino F; Chiara S; Donadio M; Facchini V; Fioretti P; Foglia G; Gadducci A; Gallo L
J Clin Oncol; 1991 Apr; 9(4):658-63. PubMed ID: 2066762
[TBL] [Abstract][Full Text] [Related]
14. Preliminary experience with intraperitoneal catheters in the treatment of ovarian cancer.
Mählck CG; Rogo KO; Stendahl U
In Vivo; 1991; 5(2):119-21. PubMed ID: 1768780
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot study.
Dufour P; Maloisel F; Bergerat JP; Barats JC; Dellenbach P; Renaud R; Ritter P; Herbrecht R; Wendling C; Audhuy B
Bull Cancer; 1991; 78(3):273-80. PubMed ID: 2054526
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
[TBL] [Abstract][Full Text] [Related]
17. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer.
Aoki Y; Takakuwa K; Kodama S; Tanaka K; Takahashi M; Tokunaga A; Takahashi T
Cancer Res; 1991 Apr; 51(7):1934-9. PubMed ID: 2004379
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.
Lévi F; Benavides M; Chevelle C; Le Saunier F; Bailleul F; Misset JL; Regensberg C; Vannetzel JM; Reinberg A; Mathé G
J Clin Oncol; 1990 Apr; 8(4):705-14. PubMed ID: 2179481
[TBL] [Abstract][Full Text] [Related]
19. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.
Alberts DS; Green S; Hannigan EV; O'Toole R; Stock-Novack D; Anderson P; Surwit EA; Malvlya VK; Nahhas WA; Jolles CJ
J Clin Oncol; 1992 May; 10(5):706-17. PubMed ID: 1569443
[TBL] [Abstract][Full Text] [Related]
20. [A case of ovarian cancer with liver metastasis successfully treated by PAC therapy].
Yokoyama H; Murakami T; Akagi T; Sunahori K; Muta M
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1203-7. PubMed ID: 2053778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
